Androgen receptor degradation by the proteolysis-targeting chimera ARCC-4 outperforms enzalutamide in cellular models of prostate cancer drug resistance - Concepedia

Concepedia

Publication | Open Access

Androgen receptor degradation by the proteolysis-targeting chimera ARCC-4 outperforms enzalutamide in cellular models of prostate cancer drug resistance

DOI Full Paper Access

334

Citations

34

References

2018

Year

Jemilat Salami, Shanique Alabi, Ryan R. Willard, Nick J. Vitale, Jing Wang, Hanqing Dong, Meizhong Jin, Donald P. McDonnell, Andrew P. Crew, Taavi K. Neklesa,

Communications Biology

References

	Year	Citations

Page 1